ECONOMY & MARKETS

IBTimes Logo

Calix Shares to Sell Off Modestly on Tuesday: Analyst

Jefferies & Co. expects that shares of Calix, Inc. (NYSE: CALX) will sell off modestly on Tuesday as investors contemplate another round of very conservative guidance from the company. The brokerage reiterated its buy rating on shares of Calix, while increasing its price target to $24.50 from $16.
More news
Trichet President of ECB addresses the media during his monthly news conference at the ECB headquarters in Frankfurt

3 Reasons to Short the Euro after April 7

On April 7, European Central Bank president Jean-Claude Trichet will almost certainly announce a 0.25 percent interest rate hike. After April 7, the best short-term play is probably to short the euro
IBTimes Logo

VeriSign to Repurchase More Shares: Analyst

Wedbush Securities expects VeriSign Inc. (NASDAQ: VRSN) to continue to return capital to investors through 2011. The brokerage maintained its neutral rating on shares of VeriSign with a price target of $38.
A picture illustration shows U.S. dollar bank notes

Why the US dollar fell in Q1 2011

The US dollar continued to fall in Q1 2011. It lost 2.4 percent against G10 currencies, similar to the pace of decline in Q4 2010 but more moderate compared to the 8.4 percent QE2-induced drop in Q3 2010.
Gold bars are displayed at a branch of Mitsubishi Materials Corporation in Tokyo

Gold Bullish, Silver Called A Classic Bubble

The Gold Price rose early Monday in London, nearing last week's high of $1439 per ounce as energy prices led a surge in commodity prices and Silver Bullion jumped 1.9% to fresh 31-year highs.

Pre-Market NASDAQ Movers (MSSR, VVUS, OREX, CIGX, OPTR, OVTI, DEPO, AMTD, LOGI, CHKP)

The top pre-market NASDAQ Stock Market gainers are: McCormick & Schmick's Seafood Restaurants, VIVUS, Orexigen Therapeutics, Star Scientific, and Optimer Pharmaceuticals. The top pre-market NASDAQ Stock Market losers are: OmniVision Technologies, DepoMed, TD AMERITRADE Holding, Logitech International, and Check Point Software Technologies.
IBTimes Logo

Bats worth up to $53 bln to U.S. economy: study

A professor from the University of Tennessee analyzed the economic impact of the loss of bats in North America in agriculture and found it to be roughly $22.9 billion a year, with the extremes ranging as low as $3.7 and $53 billion a year.
Traders work on the floor of the New York Stock Exchange

World Market Overview 4/4/2011

U.S. stocks ended higher on Friday on strong jobs data. The Dow Jones industrial average gained 56.99 points, or 0.46 percent, to 12,376.72. The Standard & Poor's 500 advanced 6.58 points, or 0.50 percent, to 1,332.41. The Nasdaq Composite rose 8.53 points, or 0.31 percent, to 2,789.60.
Follow

World Market Overview 04/04/2011

The Australian stock market closed higher on Friday on stronger international oil prices and as investors looked past overseas negatives to forthcoming economic data from the United States.
Chairman of the Federal Reserve Ben Bernanke

Fed discount window borrowing topped $110-bin at crisis peak

During the height of the financial crisis, banks around the world lined up to borrow money from the discount window of the Federal Reserve. In the few months before and after Lehman Brother’s collapse on September 15, 2008, billions were lent out.
IBTimes Logo

Motorola Xoom But Not Yet Zoom

The amount of competitive new launches near-term is making it a little bit tougher for Motorola Mobility, especially for its Xoom tablet.
Broadcom CEO Scott McGregor stands in front of the company's logo in Taipei

Strong OTN Growth Attract New Players (PMCS, BRCM, NETL, ALTR)

Auriga USA LLC expects optical transport network to get increasingly crowded with players like PMC-Sierra Inc. (PMCS), Broadcom Corp. (BRCM), NetLogic Microsystems Inc. (NETL), and potentially even FPGA (field-programmable gate array) vendor Altera Corp. (ALTR) vying to build application specific standard products (ASSP) to target this space.
Traders work on the floor of the New York Stock Exchange

World Market Update 01/04/2011

U.S. stocks ended mixed on Thursday as investors awaited Friday’s Bureau of Labor Statistics jobs report, while slightly weaker-than-expected economic reports on jobless claims and Chicago Purchasing Managers index weighed on the sentiment.

Biogen Idec Shares Hit New High on Start of Late-Stage ALS Drug Trial

Shares of Biogen Idec Inc. (NASDAQ: BIIB) touched a new 52-week high of $73.53 on Thursday. The company and its partner Knopp Biosciences announced enrollment of the first patient in EMPOWER, a multi-national Phase III study evaluating the efficacy, safety and pharmacokinetics of dexpramipexole in patients with amyotrophic lateral sclerosis (ALS).

Pages

IBT Spotlight

We Help Businesses Find B2B Service Providers They Can Trust.